120 related articles for article (PubMed ID: 30509110)
1. Case series on multiple prostate re-irradiation for locally recurrent prostate cancer: something ventured, something gained.
Volpe S; Jereczek-Fossa BA; Zerini D; Rojas DP; Fodor C; Vavassori A; Romanelli P; Vigorito S; Rondi E; Comi S; Cambria R; Cattani F; Dicuonzo S; De Marco P; Beltramo G; Musi G; De Cobelli O; Marvaso G; Orecchia R
Neoplasma; 2019 Mar; 66(2):308-314. PubMed ID: 30509110
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
[TBL] [Abstract][Full Text] [Related]
3. Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study.
Matrone F; Revelant A; Fanetti G; Polesel J; Chiovati P; Avanzo M; De Renzi F; Colombo CB; Arcicasa M; De Paoli A; Franchin G; Bortolus R
Neoplasma; 2021 Jan; 68(1):216-226. PubMed ID: 33030959
[TBL] [Abstract][Full Text] [Related]
4. PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Zerini D; Jereczek-Fossa BA; Ciabattoni A; Mirri A; Bertoni F; Fersino S; D'Agostino G; Lohr F; Mortellaro G; Triggiani L; Marvaso G; Pepa M; Cuccia F; Alongi F;
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2311-2317. PubMed ID: 32583236
[TBL] [Abstract][Full Text] [Related]
5. Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.
Zerini D; Jereczek-Fossa BA; Fodor C; Bazzani F; Maucieri A; Ronchi S; Ferrario S; Colangione SP; Gerardi MA; Caputo M; Cecconi A; Gherardi F; Vavassori A; Comi S; Cambria R; Garibaldi C; Cattani F; De Cobelli O; Orecchia R
Br J Radiol; 2015 Aug; 88(1052):20150197. PubMed ID: 26055506
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
[TBL] [Abstract][Full Text] [Related]
7. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
8. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer.
Loi M; Di Cataldo V; Simontacchi G; Detti B; Bonomo P; Masi L; Desideri I; Greto D; Francolini G; Carfora V; Pezzulla D; Perna M; Carta GA; Livi L
Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):93-100. PubMed ID: 29208480
[TBL] [Abstract][Full Text] [Related]
9. "Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach.
Marvaso G; Riva G; Ciardo D; Gandini S; Fodor C; Zerini D; Colangione SP; Timon G; Comi S; Cambria R; Cattani F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Med Oncol; 2018 May; 35(6):96. PubMed ID: 29748830
[TBL] [Abstract][Full Text] [Related]
10. Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
Zilli T; Benz E; Dipasquale G; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):318-322. PubMed ID: 27475672
[TBL] [Abstract][Full Text] [Related]
11. PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
Rischke HC; Eiberger AK; Volegova-Neher N; Henne K; Krauss T; Grosu AL; Jilg CA
Adv Med Sci; 2016 Sep; 61(2):212-218. PubMed ID: 26895459
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience.
Augugliaro M; Marvaso G; Cambria R; Pepa M; Bagnardi V; Frassoni S; Pansini F; Patricia Rojas D; Colombo F; Iuliana Fodor C; Musi G; Petralia G; De Cobelli O; Cattani F; Orecchia R; Zerini D; Jereczek-Fossa BA
Phys Med; 2021 Dec; 92():62-68. PubMed ID: 34871888
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
16. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.
Chen CP; Weinberg V; Shinohara K; Roach M; Nash M; Gottschalk A; Chang AJ; Hsu IC
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):324-9. PubMed ID: 23474112
[TBL] [Abstract][Full Text] [Related]
17. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
Sobol I; Zaid HB; Haloi R; Mynderse LA; Froemming AT; Lowe VJ; Davis BJ; Kwon ED; Karnes RJ
J Urol; 2017 Jan; 197(1):129-134. PubMed ID: 27449262
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review.
Chatzikonstantinou G; Zamboglou N; Rödel C; Zoga E; Strouthos I; Butt SA; Tselis N
Strahlenther Onkol; 2017 Sep; 193(9):683-691. PubMed ID: 28623436
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Fodor A; Berardi G; Fiorino C; Picchio M; Busnardo E; Kirienko M; Incerti E; Dell'Oca I; Cozzarini C; Mangili P; Pasetti M; Calandrino R; Gianolli L; Di Muzio NG
BJU Int; 2017 Mar; 119(3):406-413. PubMed ID: 27104782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
